Immunitybio (IBRX) had the highest return in January 2020 by a US stock with a market cap of $2B+, returning 65%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Immunitybio (IBRX) | January 2020 | 65.01% |
Tesla (TSLA) | January 2020 | 53.26% |
PG&E (PCG) | January 2020 | 39.41% |
DraftKings (DKNG) | January 2020 | 34.66% |
Apellis Pharmaceuticals (APLS) | January 2020 | 32.78% |
Appian (APPN) | January 2020 | 31.99% |
Denali Therapeutics (DNLI) | January 2020 | 31.89% |
Bill Com (BILL) | January 2020 | 31.18% |
TG Therapeutics (TGTX) | January 2020 | 27.9% |
Agilysys (AGYS) | January 2020 | 27.25% |
Tandem Diabetes Care (TNDM) | January 2020 | 27.07% |
Bath & Body Works (BBWI) | January 2020 | 26.9% |
MongoDB (MDB) | January 2020 | 25.91% |
WM Technology (MAPSW) | January 2020 | 25% |
iRhythm Technologies (IRTC) | January 2020 | 24.68% |
Twilio (TWLO) | January 2020 | 24.33% |
Impinj (PI) | January 2020 | 22.64% |
Dynatrace Holdings LLC (DT) | January 2020 | 22.45% |
Goosehead Insurance (GSHD) | January 2020 | 22.43% |
Zai Lab (ZLAB) | January 2020 | 22.13% |
Crowdstrike (CRWD) | January 2020 | 22.11% |
Sunrun (RUN) | January 2020 | 21.73% |
Ultragenyx (RARE) | January 2020 | 21.7% |
SLM (SLM) | January 2020 | 21.6% |
Soleno Therapeutics (SLNO) | January 2020 | 21.4% |
